Close Menu

Research into the role of plasma proteins on the human disease phenome is reported in Nature Genetics this week. Plasma proteins are known to be involved in a range of biological functions and have become a major source of druggable targets. To further investigate, a team led by scientists from the University of Bristol used Mendelian randomization (MR) and colocalization to estimate the effects of 1,002 proteins on 225 phenotypes, including 153 diseases and 72 risk factors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.